Integrated analysis of DNA copy number and gene expression data in Lung Cancer models of resistance to targeted therapy

Autor: Fustaino V(1, Presutti D(1), Cardinali B(1), Colombo T(3), Papoff G(1), Santini S(1), Lalli C(1), Giannini G(4), Brandi R(5), Arisi I(5), D'Onofrio M(5), Felici G(2), Ruberti G(1)

Publikováno v: BITS Annual Meeting, Roma, 26-28 Febbraio 2014
info:cnr-pdr/source/autori:Fustaino V(1,2), Presutti D(1), Cardinali B(1), Colombo T(3), Papoff G(1), Santini S(1), Lalli C(1), Giannini G(4), Brandi R(5), Arisi I(5), D'Onofrio M(5), Felici G(2) and Ruberti G(1)/congresso_nome:BITS Annual Meeting/congresso_luogo:Roma/congresso_data:26-28 Febbraio 2014/anno:2014/pagina_da:/pagina_a:/intervallo_pagine

Motivation: Tyrosine Kinase inhibitors (TKIs) constitute the most promising frontier of the last decade in the field of cancer treatment. However, the development of resistance mechanisms often makes the tumour insensitive to TKI-targeted therapy. Id

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::785406880a92dcfb33e4c34f9d0a6955
https://publications.cnr.it/doc/287458